Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient access. The high closure rate of trial sites reflects unique research objectives ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the Company that explains ...
This workshop will explore how health literacy among clinical research participants might contribute to high-quality clinical care. Presentations will explore approaches for developing clinical ...
A multimodal analysis of CT radiomics and clinical variables in predicting immunotherapy response for NSCLC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results